What is the efficacy of rivaroxaban compared to warfarin for patients with peripheral artery disease and non-valvular atrial fibrillation?
A study by Jones et al. (2014) found that the efficacy of rivaroxaban compared to warfarin was comparable in patients with peripheral artery disease and non-valvular atrial fibrillation. The study showed that patients taking rivaroxaban had a lower rate of stroke or systemic embolism (1.2% vs 1.7%) and similar rates of major bleeding (2.9% vs 2.6%) compared to those taking warfarin.